Your search returned 9 results.

Results
	1.	Implications of chronobiology for 5-fluorouracil (5-FU) efficacy. [electronic resource] by Lévi, F Brienza, S Metzer, G Deprés-Brummer, P Bertheault-Cvitkovic, F Zidani, R Adam, R Misset, J L Producer: 19940607 In: Advances in experimental medicine and biology vol. 339 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinoma. [electronic resource] by Bertheault-Cvitkovic, F Lévi, F Soussan, S Brienza, S Adam, R Itzhaki, M Misset, J L Bismuth, H Producer: 19940125 In: European journal of cancer (Oxford, England : 1990) vol. 29A Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	[Treatment of breast cancer after 70 years of age. Report of 1143 cases]. [electronic resource] by Garbay, J R Bertheault-Cvitkovic, F Cohen-Solal Le Nir, C Stevens, D Cherel, P Berlie, J Rouesse, J Producer: 19990121 In: Chirurgie; memoires de l'Academie de chirurgie vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer. [electronic resource] by Bertheault-Cvitkovic, F Jami, A Ithzaki, M Brummer, P D Brienza, S Adam, R Kunstlinger, F Bismuth, H Misset, J L Lévi, F Producer: 19961217 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients. [electronic resource] by Garufi, C Brienza, S Pugliese, P Aschelter, A M Bertheault-Cvitkovic, F Nisticò, C Giunta, S Caterino, M Giannarelli, D Cosimelli, M Lévi, F Terzoli, E Producer: 20010118 In: Anti-cancer drugs vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. [electronic resource] by Giacchetti, S Itzhaki, M Gruia, G Adam, R Zidani, R Kunstlinger, F Brienza, S Alafaci, E Bertheault-Cvitkovic, F Jasmin, C Reynes, M Bismuth, H Misset, J L Lévi, F Producer: 19991008 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients. [electronic resource] by Seitz, J-F Bennouna, J Paillot, B Gamelin, E François, E Conroy, T Raoul, J-L Becouarn, Y Bertheault-Cvitkovic, F Ychou, M Nasca, S Fandi, A Barthelemy, P Douillard, J-Y Producer: 20030123 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. [electronic resource] by Bécouarn, Y Ychou, M Ducreux, M Borel, C Bertheault-Cvitkovic, F Seitz, J F Nasca, S Nguyen, T D Paillot, B Raoul, J L Duffour, J Fandi, A Dupont-André, G Rougier, P Producer: 19980831 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours. [electronic resource] by Delord, J P Pierga, J Y Dieras, V Bertheault-Cvitkovic, F Turpin, F L Lokiec, F Lochon, I Chatelut, E Canal, P Guimbaud, R Mery-Mignard, D Cornen, X Mouri, Z Bugat, R Producer: 20050421 In: British journal of cancer vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)